Results 241 to 250 of about 187,044 (318)
Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race
Mindy Magee +3 more
openalex +2 more sources
Addressing Causality and Homogeneity Assumptions in Exposure‐Response Analyses
Exposure‐response, or pharmacokinetic–pharmacodynamic (PKPD), analyses support many drug development decisions. It is typically applied without assessment of causality and homogeneity, where the latter refers to the assumption that the reason for variability in exposure is unimportant for the impact on response.
Mats O. Karlsson, Divya Brundavanam
wiley +1 more source
Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Remimazolam. [PDF]
Murrell DE, Harirforoosh S.
europepmc +1 more source
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park +22 more
wiley +1 more source
Asundexian: a systematic review of safety, efficacy, and pharmacological insights in thrombosis. [PDF]
Aldeen ZS +8 more
europepmc +1 more source
Verekitug, a novel, high‐affinity, fully human monoclonal antibody targeting thymic stromal lymphopoietin receptor (TSLPR), is in development as a potential treatment for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD).
Dave Singh +9 more
wiley +1 more source
Correction: Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis <i>in vivo</i> and <i>in vitro</i>. [PDF]
Chen K +9 more
europepmc +1 more source
The European Medicines Regulatory Network plays a critical role in safeguarding public health through the assessment and supervision of human medicines. However, rapid scientific and technological advancements have exposed capability deficits across the network, threatening timely and effective regulatory decision‐making.
Naomi Beard +4 more
wiley +1 more source

